Methyl 4-(bromo­meth­yl)benzoate by Yathirajan, H. S. et al.
organic papers
o1334 Yathirajan et al.  C9H9BrO2 doi:10.1107/S1600536807007258 Acta Cryst. (2007). E63, o1334–o1335
Acta Crystallographica Section E
Structure Reports
Online
ISSN 1600-5368
Methyl 4-(bromomethyl)benzoate
H. S. Yathirajan,a S. Bindya,a
B. K. Sarojini,b B. Narayanac and
Michael Bolted*
aDepartment of Studies in Chemistry, University
of Mysore, Manasagangotri, Mysore 570 006,
India, bDepartment of Chemistry, P. A. College
of Engineering, Nadupadavu, Mangalore 574
153, India, cDepartment of Chemistry,
Mangalore University, Mangalagangotri 574
199, India, and dInstitut fu¨r Anorganische
Chemie, J. W. Goethe-Universita¨t Frankfurt,
Max-von-Laue-Strasse 7, 60438 Frankfurt/Main,
Germany
Correspondence e-mail:
bolte@chemie.uni-frankfurt.de
Key indicators
Single-crystal X-ray study
T = 173 K
Mean (C–C) = 0.005 A˚
R factor = 0.048
wR factor = 0.123
Data-to-parameter ratio = 19.5
For details of how these key indicators were
automatically derived from the article, see
http://journals.iucr.org/e.
Received 12 February 2007
Accepted 12 February 2007
# 2007 International Union of Crystallography
All rights reserved
The ester group of the title compound, C9H9BrO2, is only
slightly twisted out of the plane of the central aromatic ring.
Geometric parameters are in the usual ranges.
Comment
The title compound, (I), is a lachrymator and a drug inter-
mediate. Methyl 4-(bromomethyl)benzoate is widely
employed in synthetic organic chemistry and has wide appli-
cations (Liu et al., 2001; Tang et al., 2006). Recently, the title
compound was used to synthesize methyl 4-[(2-butyl-4-chloro-
5-formyl-1H-imidazol-1-yl)methyl]benzoate (Yang et al.,
2004). In addition, methyl 4-(bromomethyl)benzoate has been
used in the synthesis of 1-(carboxybenzy1)imidazole-5-acrylic
acids, which are potent and selective angiotensin II receptor
antagonists (Weinstock et al., 1991).
A perspective view of (I) is shown in Fig. 1. Bond lengths
and angles can be regarded as normal (Cambridge Structural
Database, Version 5.28, November 2006; Mogul Version 1.1;
Allen, 2002, Bruno et al., 2004). The ester group is twisted by
only 9.88 (19) out of the plane of the central aromatic ring.
There are no short C—H  X contacts, but one – stacking
interaction can be observed in the crystal packing (Fig. 2).
Carboxylate atom C7 is located above the centre of the
aromatic ring of a neighboring parallel molecule (at x  1, y,
z) at a distance of 3.585 A˚.
Figure 1
The molecular structure of the title compound with the atom numbering;
displacement ellipsoids are drawn at the 50% probability level.
Experimental
N-Bromosuccinimide (23.9 g, 0.133 mol) and benzoyl peroxide
(0.41 g, 0.0017 mol) were added to methyl 4-methylbenzoate (20 g,
0.133 mol) in 100 ml carbon tetrachloride and heated to reflux while
irradiating with light (IR lamp). The reaction mixture was filtered and
the filtrate was concentrated after washing with NaHCO3 solution
and dried over anhydrous Na2SO4. The resulting title compound was
crystallized by slow evaporation of a solution in acetone (yield 75%;
m.p. 325–327 K). Analysis found/calculated (%) for C9H9BrO2: C
47.01/47.19, H 3.88/3.96.
Crystal data
C9H9BrO2
Mr = 229.07
Orthorhombic, P212121
a = 4.4481 (3) A˚
b = 6.1860 (3) A˚
c = 33.048 (2) A˚
V = 909.35 (9) A˚3
Z = 4
Mo K radiation
 = 4.47 mm1
T = 173 (2) K
0.25  0.13  0.12 mm
Data collection
Stoe IPDS-II two-circle
diffractometer
Absorption correction: multi-scan
(MULABS; Spek, 2003;
Blessing, 1995)
Tmin = 0.401, Tmax = 0.616
(expected range = 0.380–0.584)
13106 measured reflections
2164 independent reflections
2052 reflections with I > 2(I)
Rint = 0.062
Refinement
R[F 2 > 2(F 2)] = 0.048
wR(F 2) = 0.123
S = 1.05
2164 reflections
111 parameters
H-atom parameters constrained
max = 1.05 e A˚
3
min = 0.63 e A˚3
Absolute structure: Flack (1983),
837 Friedel pairs
Flack parameter: 0.002 (18)
H atoms were found in a difference map, but were refined using a
riding model, with C—H = 0.95–0.99 A˚ and Uiso(H) = 1.2Ueq(C) or
Uiso(H) = 1.5Ueq(methyl C). The methyl groups were allowed to
rotate but not to tip.
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement: X-
AREA; data reduction: X-AREA; program(s) used to solve structure:
SHELXS97 (Sheldrick, 1997); program(s) used to refine structure:
SHELXL97 (Sheldrick, 1997); molecular graphics: PLATON (Spek,
2003); software used to prepare material for publication:
SHELXL97.
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Figure 2
Packing diagram of the title compound. – Stacking interactions shown
as dashed lines.
